Navigation Links
Achilles heel: Popular drug-carrying nanoparticles get trapped in bloodstream
Date:2/5/2013

sease in the blood vessels or the tissue beyond.

With their recent work, including a study to be published recently in Langmuir, Eniola-Adefeso's team has shown that nanoparticle spheres face this problem in tiny arterioles and venulesone step up from capillariesall the way up to centimeter-sized arteries.

They discovered this with the help of plastic channels lined with the same cells that make up the interiors of blood vessels. Human blood, with added nano- or microspheres, ran through the channels, and the team observed whether or not the spheres migrated to the channel walls and bound themselves to the lining. The researchers present the first visual evidence that few nanospheres make it to the vessel wall in blood flow.

"Prior to the work that we have done, people were operating under the assumption that particles will interact with the blood vessel at some point," Eniola-Adefeso said.

While a relatively small fraction of nanospheres filter out to the blood vessel walls, many more stay in the bloodstream and travel all over the body. Increasing the nanoparticle dose gives poor returns; after the team added five times more nanospheres to the blood samples, the number of spheres that bonded with the blood vessel lining only doubled.

"If localized drug delivery is an important goal, then nanospheres will fail," she said.

But it's not all bad news. The red blood cells tended to push microspheres with diameters of two microns or more toward the wall. Whether the blood flowed evenly, as it does in arterioles and venules, or in pulses, as occurs in arteries, the larger microspheres were able to reach the vessel wall and bind to it. When the team added more microspheres to the flow, they saw a proportional increase in microspheres on the vessel wall.

While microspheres are too large to serve as drug carriers into cell or tissue space on their own, the team suggested that microspheres could ferry na
'/>"/>

Contact: Kate McAlpine
kmca@umich.edu
734-763-4386
University of Michigan
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Researchers identify Achilles heel of dengue virus, target for future vaccines
2. An Achilles heel of AML
3. Scientists find Achilles heel in life-threatening malaria parasites
4. CYCLOPS genes may serve as an Achilles heel in tumor cells
5. Researchers reveal a chemo-resistant cancer stem cell as cancers Achilles heel
6. Experiment finds ulcer bugs Achilles heel
7. Achilles heel of pathogenic bacteria discovered
8. Pitt team finds Achilles Heel of key HIV replication protein
9. UNH research adds to mounting evidence against popular pavement sealcoat
10. ONR-funded research takes flight in Popular Science article
11. Medbox Safe Storage and Access Lockers Gaining Popularity
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/18/2014)... A survey of emergency contraceptive pills in Peru ... were either of substandard quality or falsified. Many ... had the wrong active ingredient. One batch had ... detect the fake drugs, researchers at the Georgia ... mass spectrometry to quickly assess suspected counterfeit drugs ...
(Date:4/18/2014)... a twist to the story of how barnyard chickens came ... in the journal Proceedings of the National Academy of ... that lived 200-2300 years ago in Europe, researchers report that ... looked far different from the chickens we know today. , ... with modern domestic chickens -- such as their yellowish skin ...
(Date:4/17/2014)... In the most densely forested and most densely populated ... of human needs, values and practices. Disturbances associated with ... agriculture and development, have set the stage for management ... study reports. , The report Five anthropogenic factors ... in the Northern United States was published ...
Breaking Biology News(10 mins):Counterfeit contraceptives found in South America 2Counterfeit contraceptives found in South America 3Ancient DNA offers clues to how barnyard chickens came to be 2Five anthropogenic factors that will radically alter northern forests in 50 years 2Five anthropogenic factors that will radically alter northern forests in 50 years 3
... S.C., Sept. 17, 2012   Eliza Corporation ("Eliza") , the ... BlueCross BlueShield of South Carolina ("BlueCross") announced ... members increased 45 percent over 2011 rates. In fact, ... exceeded expectations in all areas, and as a result ...
... Research Institute and Sea Lane Biotechnologies have solved the co-crystal ... in a unique way. The antibody recognizes the crucial structure ... though previously this structure had been thought too small for ... hit this precise spot by using just a small part ...
... developed a method that for the first time provides ... and subsequently remove them in a repeatable cycle., Their ... week in the journal Nature Methods , will ... formed proteins in order to create better antibiotics, anti-cancer ...
Cached Biology News:Eliza Corporation and BlueCross BlueShield of South Carolina Drive Awareness and Healthier Behavior to Increase Colorectal Cancer Screenings by 45 Percent 2Eliza Corporation and BlueCross BlueShield of South Carolina Drive Awareness and Healthier Behavior to Increase Colorectal Cancer Screenings by 45 Percent 3Eliza Corporation and BlueCross BlueShield of South Carolina Drive Awareness and Healthier Behavior to Increase Colorectal Cancer Screenings by 45 Percent 4Flu antibody’s 'one-handed grab' may boost effort toward universal vaccine, new therapies 2Flu antibody’s 'one-handed grab' may boost effort toward universal vaccine, new therapies 3Chemists develop reversible method of tagging proteins 2Chemists develop reversible method of tagging proteins 3
(Date:1/15/2014)... Two champions of science, technology, engineering, ... an annual competition for middle and high school students ... STEM study. The competition presents students with real-world problems ... Aptitude, Mathematics, and Sciences is a program administered ...
(Date:1/15/2014)... Raleigh, NC (PRWEB) January 15, 2014 ... enhancement to its Online Web Portal for Life Science organizations ... ability to specify the subject matter of their documents in ... This will help reduce time-to-delivery of translations, often a critical ...
(Date:1/15/2014)... January 15, 2014 Freeslate, Inc ... today announced that Lupin Limited, one of India’s top ... CM Protégé PharmD System for high throughput solid ... is focused on a wide range of quality, affordable ...
(Date:1/15/2014)... Jan. 15, 2014 TaiGen Biotechnology Company, Limited ("TaiGen") ... with R-Pharm, a leading Russian pharmaceutical company, to develop ... Russian Federation , Turkey ... (CIS). Nemonoxacin is a novel antibiotic for the treatment of ...
Breaking Biology Technology:Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 2Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 3Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 4Technology Student Association Partners with Leaders in STEM Education Advocacy for Annual Competition 5DTS Improves Efficiency for Life Science Document Translations 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 2Lupin Selects Freeslate’s CM Protégé PharmD System to Accelerate Polymorph Screening for Drug Development 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 2TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 3TaiGen Biotechnology Signed Exclusive License Agreement with R-Pharm for Nemonoxacin (Taigexyn(R)) 4
... Progression-free Survival with Campath, CAMBRIDGE, Mass. and ... GENZ ) and Bayer HealthCare Pharmaceuticals Inc.,(NYSE: ... and Drug Administration,(FDA) has approved a supplemental biologics ... approval for single-agent,Campath for the treatment of B-cell ...
... LOS ANGELES, Sept. 20 Signalife announced,today that it ... (two,million dollars) of Fidelity 100 units thus far in ... which anticipates additional sales,orders resulting from its current efforts, ... About Signalife: Signalife, Inc. is an award-winning ...
... Inc.,(TSX: AEZ; Nasdaq: AEZS), a global biopharmaceutical company focused ... and CEO,David J. Mazzo, Ph.D., will present a Company ... September 27, 2007 at 10:00 a.m.,Eastern, in the Ballroom ... City. A live webcast of this presentation will ...
Cached Biology Technology:FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 2FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 3FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 4FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 5FDA Approves Expanded Labeling for Campath(R) to Include First-line Treatment for Leading Form of Adult Leukemia 6Signalife Achieves $1.98 Million Sales Orders Thus Far 2